Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry

Objective: This study examines asthma risk in facilities producing toluene diisocyanate (TDI). Methods: A total of 197 workers were monitored from 2007 to 2012. TDI air concentrations were used to estimate exposures. Results: The incidence of cases consistent with TDI-induced asthma was 0.009 per person-years (seven cases) or consistent with TDI-induced asthma or asthma indeterminate regarding work-relatedness was 0.012 (nine cases). Increased risk of cases consistent with TDI asthma was observed for cumulative (odds ratio [OR] = 2.08, 95% confidence interval [CI] 1.07 to 4.05) per logarithm parts per billion-years and peak TDI exposures (OR = 1.18, 95% CI 1.06 to 1.32) (logarithm parts per billion). There was a weak association with cumulative and peak exposures for decline of short-term forced expiratory volume in one second (FEV1). Asthma symptoms were associated with workers noticing an odor of TDI (OR 6.02; 95% CI 1.36 to 26.68). Conclusions: There is evidence that cumulative and peak exposures are associated with TDI-induced asthma.

[1]  L. Cassidy,et al.  Medical Monitoring for Occupational Asthma Among Toluene Diisocyanate Production Workers in the United States , 2017, Journal of occupational and environmental medicine.

[2]  T. Feeley,et al.  Toluene Diisocyanate Exposure: Exposure Assessment and Development of Cross-Facility Similar Exposure Groups Among Toluene Diisocyanate Production Plants , 2017, Journal of occupational and environmental medicine.

[3]  L. Cassidy,et al.  Longitudinal and Cross-sectional Analyses of Lung Function in Toluene Diisocyanate Production Workers , 2017, Journal of occupational and environmental medicine.

[4]  J. Mazurek,et al.  Occupation held at the time of asthma symptom development. , 2013, American journal of industrial medicine.

[5]  J. Moorman,et al.  Asthma Incidence among Children and Adults: Findings from the Behavioral Risk Factor Surveillance System Asthma Call-back Survey—United States, 2006–2008 , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[6]  J. Malo,et al.  Medical surveillance programme for diisocyanate exposure , 2010, Occupational and Environmental Medicine.

[7]  D. Hendrick.  Recognition and surveillance of occupational asthma: a preventable illness with missed opportunities. , 2010, British medical bulletin.

[8]  K. Torén,et al.  Asthma caused by occupational exposures is common – A systematic analysis of estimates of the population-attributable fraction , 2009, BMC pulmonary medicine.

[9]  P. Hunt,et al.  A longitudinal study of adult-onset asthma incidence among HMO members , 2003, Environmental health : a global access science source.

[10]  M. G. Ott,et al.  Respiratory Effects of Toluene Diisocyanate in the Workplace: A Discussion of Exposure-Response Relationships , 2003, Critical reviews in toxicology.

[11]  P. Conner.  Experience with early detection of toluene diisocyanate-associated occupational asthma. , 2002, Applied occupational and environmental hygiene.

[12]  W. Diller.  Frequency and trends of occupational asthma due to toluene diisocyanate: a critical review. , 2002, Applied occupational and environmental hygiene.

[13]  G. Liss,et al.  Diisocyanate-induced asthma: diagnosis, prognosis, and effects of medical surveillance measures. , 2002, Applied occupational and environmental hygiene.

[14]  M. Karol,et al.  Diisocyanate asthma: clinical aspects and immunopathogenesis. , 2002, International immunopharmacology.

[15]  G. Liss,et al.  Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures , 2002, Occupational and environmental medicine.

[16]  A. Draper,et al.  Occupational Asthma , 2002, The Journal of asthma : official journal of the Association for the Care of Asthma.

[17]  A. Wisnewski,et al.  Recent developments in diisocyanate asthma , 2001, Current opinion in allergy and clinical immunology.

[18]  M. G. Ott,et al.  Respiratory health surveillance in a toluene di-isocyanate production unit, 1967–97: clinical observations and lung function analyses , 2000, Occupational and environmental medicine.

[19]  L. Davis,et al.  Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments--California, Massachusetts, Michigan, and New Jersey, 1993-1995. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[20]  D. Postma,et al.  Decline of FEV1 by age and smoking status: facts, figures, and fallacies. , 1997, Thorax.

[21]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[22]  Dr S Meredith.  Occupational asthma: measures of frequency from four countries. , 1996, Thorax.

[23]  J. Mcdonald,et al.  SWORD '94: surveillance of work-related and occupational respiratory disease in the UK. , 1995, Occupational medicine.

[24]  J. Mcdonald,et al.  SWORD '98: surveillance of work-related and occupational respiratory disease in the UK. , 1994, Occupational medicine.

[25]  R. Rousseau,et al.  Occupational respiratory diseases in British Columbia, Canada in 1991. , 1994, Occupational and environmental medicine.

[26]  S. Meredith.  Reported incidence of occupational asthma in the United Kingdom, 1989-90. , 1993, Journal of epidemiology and community health.

[27]  I. Bernstein,et al.  The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. , 1993, The Journal of allergy and clinical immunology.

[28]  M. Lara,et al.  Guidelines For The Diagnosis And Management Of Asthma , 1992, The Journal of the American Board of Family Medicine.

[29]  C. O'neil,et al.  Abnormal lung function in polyurethane foam producers. Weak relationship to toluene diisocyanate exposures. , 1992, The American review of respiratory disease.

[30]  D. Wegman,et al.  Epidemiology of toluene diisocyanate (TDI)-induced respiratory disease. , 1975, Environmental health perspectives.

[31]  L. Scheel,et al.  A retrospective study of clinical, physiologic and immunologic changes in workers exposed to toluene diisocyanate. , 1975, American Industrial Hygiene Association journal.

[32]  Imperial,et al.  Long-term effects on the health of men engaged in the manufacture of tolylene di-isocyanate. , 1975, British journal of industrial medicine.

[33]  K. Williamson.  Studies of diisocyanate workers. (2). , 1964, The Transactions of the Association of Industrial Medical Officers.

[34]  Woodbury Jw.  Asthmatic syndrome following exposure to tolylene diisocyanate. , 1956 .

[35]  E. Eisen,et al.  The healthy worker effect in asthma: work may cause asthma, but asthma may also influence work. , 2008, American journal of respiratory and critical care medicine.

[36]  Ott Mg,et al.  Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-97: clinical observations and lung function analyses. , 2000 .